Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points

Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant

Sample kidneys (yellow) and tumor (green) maps delineated on CT

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Radiation Dosimetry in 177Lu-PSMA-617 Therapy - ScienceDirect

Radiation Dosimetry in 177Lu-PSMA-617 Therapy - ScienceDirect

PDF) Towards Single Time Point Image-Based Dosimetry of 177 Lu

Is a single late SPECT/CT based kidney 177Lu-dosimetry superior to

Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T

Frontiers Towards Routine Clinical Use of Dosimetry in [177Lu]Lu

How We Do It: A Multidisciplinary Approach to 177Lu DOTATATE

xSPECT Quant-based dosimetry following 177Lu PSMA therapy in

Development of 177Lu-scFvD2B as a Potential Immunotheranostic

Evaluation of absorbed dose using sequential quantitative SPECT/CT